CO5650216A2 - Estuche para uso farmaceutico - Google Patents

Estuche para uso farmaceutico

Info

Publication number
CO5650216A2
CO5650216A2 CO05092523A CO05092523A CO5650216A2 CO 5650216 A2 CO5650216 A2 CO 5650216A2 CO 05092523 A CO05092523 A CO 05092523A CO 05092523 A CO05092523 A CO 05092523A CO 5650216 A2 CO5650216 A2 CO 5650216A2
Authority
CO
Colombia
Prior art keywords
nutrient
administered
once
active ingredient
active
Prior art date
Application number
CO05092523A
Other languages
English (en)
Inventor
Richard James Cawthray
Vincent Anthony Difabritus
Ellen Mary Loughren
Kurt Franklin Trombley
Der Geest Stephanus Alexander Paulus Van
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33131725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5650216(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of CO5650216A2 publication Critical patent/CO5650216A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
  • Exchange Systems With Centralized Control (AREA)
  • Telephone Function (AREA)
  • Packages (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1.- Un estuche para promover la administración oral secuencial apropiada de un ingrediente farmacéuticamente activo y nutrientes acompañantes; el estuche se caracteriza por:a) Al menos una dosis unitaria de un activo farmacéutico para ser administrada R2 se selecciona independientemente de hidrógeno, halo, ciano, hidroxilo, carboxi, ceto, tioceto, aminada continuamente con una frecuencia de una vez por semana, dos veces por semana, una vez cada dos semanas, dos veces al mes, o una ves al mes;b) al menos una dosis unitaria de un nutriente para ser administrado subsiguiente a la administración de la dosis del activo; y c) un envase blister que contiene las dosis unitarias individualmente y en forma que se pueda liberar;caracterizado porque las dosis unitarias del activo farmacéutico y el nutriente están dispuestos horizontal o verticalmente siguiendo el orden de su uso de un extremo a otro del envase blister.
CO05092523A 2003-03-26 2005-09-13 Estuche para uso farmaceutico CO5650216A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45786503P 2003-03-26 2003-03-26

Publications (1)

Publication Number Publication Date
CO5650216A2 true CO5650216A2 (es) 2006-06-30

Family

ID=33131725

Family Applications (1)

Application Number Title Priority Date Filing Date
CO05092523A CO5650216A2 (es) 2003-03-26 2005-09-13 Estuche para uso farmaceutico

Country Status (27)

Country Link
US (2) US20040188316A1 (es)
EP (1) EP1605890B1 (es)
JP (1) JP4865332B2 (es)
KR (1) KR100775795B1 (es)
CN (1) CN100493486C (es)
AT (1) ATE526003T1 (es)
AU (1) AU2004226326B2 (es)
BR (1) BRPI0408770B1 (es)
CA (1) CA2517102A1 (es)
CO (1) CO5650216A2 (es)
CY (1) CY1112964T1 (es)
DK (1) DK1605890T5 (es)
ES (1) ES2374273T3 (es)
HK (1) HK1086737A1 (es)
HR (1) HRP20050824B1 (es)
HU (1) HU3526U (es)
IL (1) IL170830A (es)
IS (1) IS2883B (es)
MA (1) MA27723A1 (es)
MX (1) MXPA05010198A (es)
NO (1) NO333084B1 (es)
NZ (1) NZ541856A (es)
PL (1) PL1605890T3 (es)
PT (1) PT1605890E (es)
RU (1) RU2314786C2 (es)
SI (1) SI1605890T1 (es)
WO (1) WO2004087038A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003055496A1 (en) * 2001-12-21 2003-07-10 The Procter & Gamble Company Method for the treatment of bone disorders
US20050070504A1 (en) * 2001-12-21 2005-03-31 The Procter & Gamble Co. Risedronate compositions and their methods of use
US20070095850A1 (en) * 2005-10-27 2007-05-03 Meyer Daniel D Multiple medication dispensing system
KR100844256B1 (ko) * 2007-03-23 2008-07-07 코오롱제약주식회사 리세드로네이트와 비타민 ｄ를 포함하는 대사성 골질환치료용 약제조성물 및 이의 제조방법
WO2009087553A1 (en) * 2008-01-02 2009-07-16 Aurobindo Pharma Limited Kits for administering bisphosphonates
EP2082717A1 (en) 2008-01-28 2009-07-29 Merz Pharma GmbH & Co. KGaA Titration package
TR200900879A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler
TR200900880A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik bileşimler.
EP2429299B1 (en) * 2009-05-01 2016-06-01 Celloxess Llc Treating male infertility secondary to sperm oxidative stress
US20160132658A1 (en) * 2014-11-09 2016-05-12 Bhuren Patel Novel multi-compartment dosage cards for split package administration
RU2017110012A (ru) * 2016-05-10 2020-06-10 Анатолий Викторович Зазуля Устройство для пожизненного приёма переменных доз геропротектора, повышения постадаптации гормезис

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58649A (en) * 1978-11-10 1982-04-30 Beecham Group Ltd Pharmaceutical dispensing container
US4534468A (en) * 1983-12-19 1985-08-13 Nuckols Walter S Calendar-oriented pill dispenser
US4736849A (en) * 1983-12-19 1988-04-12 Leonard Walter G Calendar-oriented pill dispenser
US4817819A (en) * 1985-12-19 1989-04-04 Berlex Laboratories, Inc. Container for tablets
US4958736A (en) * 1986-03-18 1990-09-25 Gynex, Inc. Package for oral contraceptive tablet
US4889238A (en) * 1989-04-03 1989-12-26 The Procter & Gamble Company Medicament package for increasing compliance with complex therapeutic regimens
US5265728A (en) * 1991-04-29 1993-11-30 Berlex Laboratories, Inc. Arrangement for retaining blister pack tablets
CA2067611A1 (en) 1991-04-29 1992-10-30 Stephan Charles Allendorf Arrangement for retaining blister pack tablets
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5484976A (en) * 1993-10-01 1996-01-16 Axis Usa, Inc. Fusing methods and apparatus for use in making dynamo-electric machines
SE9502370D0 (sv) * 1995-06-30 1995-06-30 Astra Ab Blister pack, especially for drugs, as well as method and device in manufacturing the same
SE515129C2 (sv) * 1996-07-01 2001-06-11 Astrazeneca Ab Blisterförpackning, apparat och förfarande för tillverkning av en blisterförpackning samt användning av en blisterförpackning
US5788974A (en) * 1996-09-11 1998-08-04 D'amico; Steven A. Helicobacter pylori treatment compliance pack
US6564945B1 (en) * 1997-07-14 2003-05-20 Robert E. Weinstein Medication assemblage for use in sinusitis treatment regimens
US5994329A (en) * 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
WO1999021556A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
AU4134599A (en) 1998-04-07 1999-10-25 Akzo Nobel N.V. Progestogen-only contraceptive kit
US6375956B1 (en) * 1999-07-22 2002-04-23 Drugtech Corporation Strip pack
WO2001045636A1 (en) * 1999-12-20 2001-06-28 Merck & Co., Inc. Pharmaceutical kit
US20020066691A1 (en) * 2000-12-04 2002-06-06 Varon Steven C. Therapy pack
US6651816B2 (en) * 2001-05-04 2003-11-25 Robert E. Weinstein Antihistamine/decongestant regimens for treating rhinitis
AU2002331013A1 (en) * 2001-08-09 2003-02-24 Rhodia Inc. Calcium dietary supplement
US20030168376A1 (en) * 2001-12-19 2003-09-11 Rajneesh Taneja Packaging system for separately storing and dispensing together separate medication components
US20030111479A1 (en) * 2001-12-19 2003-06-19 Rajneesh Taneja Packaging system for separately storing and dispensing together separate medication components

Also Published As

Publication number Publication date
CN100493486C (zh) 2009-06-03
AU2004226326A1 (en) 2004-10-14
JP2006520615A (ja) 2006-09-14
RU2005129534A (ru) 2006-02-27
IS8022A (is) 2005-09-12
MA27723A1 (fr) 2006-01-02
HRP20050824A2 (en) 2006-02-28
CY1112964T1 (el) 2016-04-13
PT1605890E (pt) 2011-12-21
MXPA05010198A (es) 2005-11-08
NZ541856A (en) 2007-03-30
AU2004226326B2 (en) 2008-04-17
NO333084B1 (no) 2013-02-25
SI1605890T1 (sl) 2012-02-29
DK1605890T3 (da) 2011-11-28
HU3526U (en) 2008-12-29
US20040188316A1 (en) 2004-09-30
HU0600225V0 (en) 2006-11-28
CA2517102A1 (en) 2004-10-14
US20120145588A1 (en) 2012-06-14
JP4865332B2 (ja) 2012-02-01
DK1605890T5 (da) 2012-01-23
PL1605890T3 (pl) 2012-02-29
KR100775795B1 (ko) 2007-11-12
BRPI0408770B1 (pt) 2021-06-01
WO2004087038A1 (en) 2004-10-14
EP1605890A1 (en) 2005-12-21
ATE526003T1 (de) 2011-10-15
ES2374273T3 (es) 2012-02-15
IL170830A (en) 2013-04-30
HK1086737A1 (en) 2006-09-29
IS2883B (is) 2014-06-15
KR20050111610A (ko) 2005-11-25
EP1605890B1 (en) 2011-09-28
CN1764430A (zh) 2006-04-26
RU2314786C2 (ru) 2008-01-20
HRP20050824B1 (hr) 2014-01-17
BRPI0408770A (pt) 2006-04-04
NO20054204L (no) 2005-09-09

Similar Documents

Publication Publication Date Title
CO5650216A2 (es) Estuche para uso farmaceutico
RU2356547C2 (ru) Способы лечения рака с использованием ингибиторов hdac
CA2570474A1 (en) A combination composition comprising paracetamol and ibuprofen
IT1261849B (it) Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
MX2023006414A (es) Paquete de dosificacion unitaria y metodos para administrar medicaciones de perdida de peso.
RU2010133489A (ru) Применение ингибиторов гамма-секретазы для лечения рака
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
AR037592A1 (es) Formulaciones farmaceuticas de 5,7,14-triazatetraciclo (10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno
RU2007132181A (ru) ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ
ATE509616T1 (de) Topische pharmazeutische und/oder cosmetische dosierungssysteme
DE60022021D1 (de) Zubereitungen enthaltend Apomorphin und Sildenafil und ihre Verwendung zur Behandlung von erektiler Dysfunktion
JP2006504795A5 (es)
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
RU2011111792A (ru) Применение парацетамола и ибупрофена в лечении
RU2010109359A (ru) Азитромицин для лечения кожных заболеваний
BRPI0413374A (pt) composições para liberação de base fraca por um perìodo estendido de tempo
DE69803670D1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
GB0018322D0 (en) Pharmaceutical compositions
AR046042A1 (es) Kit para uso farmaceutico
RU2002129356A (ru) Комбинация лекарственных средств для лечения головной боли, содержащая нестероидное противовоспалительное лекарственное средство
ATE494239T1 (de) Vorrichtung zum abgeben von pharmazeutischen produkten
ATE257377T1 (de) Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform
RU2007128308A (ru) НОВОЕ ПРИМЕНЕНИЕ РЕКОМБИНАНТА АДЕНОВИРУСА р-53 ДЛЯ ЛЕЧЕНИЯ РАКОВЫХ ПАЦИЕНТОВ
AR029327A1 (es) Uso de la levobupivacaina para la preparacion de medicamentos de aplicacion en el anestesiamiento de pacientes sujetos a intervencion de cirugia mayor

Legal Events

Date Code Title Description
FC Application refused